Connecting you to content on EBSCOhost

Works matching IS 10781552 AND DT 2010 AND VI 16 AND IP 3

Results: 8

1

Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia.

Published in:: Journal of Oncology Pharmacy Practice, 2010, v. 16, n. 3, p. 179, doi. 10.1177/1078155209351329
Publication type:: Article

2

Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation.

Published in:: Journal of Oncology Pharmacy Practice, 2010, v. 16, n. 3, p. 195, doi. 10.1177/1078155209348721
Publication type:: Article

3

Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.

Published in:: Journal of Oncology Pharmacy Practice, 2010, v. 16, n. 3, p. 205, doi. 10.1177/1078155209348719
Publication type:: Article

4

A cross-sectional study comparing variation in body surface area and chemotherapy dosing in pediatric oncology using two different methods.

Published in:: Journal of Oncology Pharmacy Practice, 2010, v. 16, n. 3, p. 189, doi. 10.1177/1078155209347403
Publication type:: Article

5

Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.

Published in:: Journal of Oncology Pharmacy Practice, 2010, v. 16, n. 3, p. 173, doi. 10.1177/1078155209347402
Publication type:: Article

6

A comparison of the rates of cisplatin (cDDP) -- induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measure.

Published in:: Journal of Oncology Pharmacy Practice, 2010, v. 16, n. 3, p. 167, doi. 10.1177/1078155209346071
Publication type:: Article

7

Evaluation of a clinical scoring scale to direct early appropriate therapy in heparin-induced thrombocytopenia.

Published in:: Journal of Oncology Pharmacy Practice, 2010, v. 16, n. 3, p. 161, doi. 10.1177/1078155209342133
Publication type:: Article

8

Busulfan systemic exposure after oral administration of extemporeanously prepared high-dose busulfan capsules.

Published in:: Journal of Oncology Pharmacy Practice, 2010, v. 16, n. 3, p. 151, doi. 10.1177/1078155209340487
Publication type:: Article